[5 Urgent Questions After The WHO Emergency Hantavirus Meeting](https://wbbsec.com/opinions-and-features/5-urgent-questions-after-the-who-emergency-hantavirus-meeting-published-in-forbes/)
[5 Urgent Questions After The WHO Emergency Hantavirus Meeting](https://wbbsec.com/opinions-and-features/5-urgent-questions-after-the-who-emergency-hantavirus-meeting-published-in-forbes/)
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

Retrophin, Gilead, and Our Healthcare Values

By:WBB SecuritiesPosted: Sep 12th, 2014In: Opinions & Features

9.12.14 | Forbes

By Steve Brozak

Have you ever wondered how our society values innovation, how it rewards breakthrough discoveries?  Most people say that it’s the price we place on new drugs that show how much we value the breakthrough. For the full article, please click here.

Recent Posts

5 Urgent Questions After The WHO Emergency Hantavirus Meeting – Published in Forbes

May 15, 2026

Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing – Published in Forbes

May 6, 2026

WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation

January 12, 2026

WBB Securities Initiates Coverage of Turn Therapeutics (Nasdaq: TTRX)

January 12, 2026

The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk

December 29, 2025

OYE Therapeutics Raises $5.475 Million Series A to Advance High-Concentration Caffeine Therapy

December 16, 2025

Previous Post

Analyst Interview with Steve Brozak: Big-Picture Biotech Stocks Rule the Future

Next Post

Why the Ebola Crisis Won’t End Without Military Intervention

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2026 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom